Nuveen Asset Management’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $275K | Hold |
45,015
| – | – | ﹤0.01% | 3145 |
|
|
2024
Q3 | $745K | Buy |
45,015
+4,266
| +10% | +$70.6K | ﹤0.01% | 2874 |
|
|
2024
Q2 | $280K | Hold |
40,749
| – | – | ﹤0.01% | 3167 |
|
|
2024
Q1 | $393K | Sell |
40,749
-9,074
| -18% | -$87.6K | ﹤0.01% | 3037 |
|
|
2023
Q4 | $414K | Sell |
49,823
-29,364
| -37% | -$244K | ﹤0.01% | 3069 |
|
|
2023
Q3 | $661K | Hold |
79,187
| – | – | ﹤0.01% | 2745 |
|
|
2023
Q2 | $731K | Sell |
79,187
-1,982
| -2% | -$18.3K | ﹤0.01% | 2785 |
|
|
2023
Q1 | $1.12M | Sell |
81,169
-1,935
| -2% | -$26.6K | ﹤0.01% | 2574 |
|
|
2022
Q4 | $1.41M | Buy |
83,104
+37,920
| +84% | +$645K | ﹤0.01% | 2528 |
|
|
2022
Q3 | $1.03M | Sell |
45,184
-42,505
| -48% | -$966K | ﹤0.01% | 2740 |
|
|
2022
Q2 | $1.58M | Buy |
87,689
+61,277
| +232% | +$1.1M | ﹤0.01% | 2557 |
|
|
2022
Q1 | $420K | Buy |
26,412
+2,530
| +11% | +$40.2K | ﹤0.01% | 3063 |
|
|
2021
Q4 | $700K | Sell |
23,882
-7,074
| -23% | -$207K | ﹤0.01% | 2975 |
|
|
2021
Q3 | $2.04M | Sell |
30,956
-8,651
| -22% | -$569K | ﹤0.01% | 2666 |
|
|
2021
Q2 | $3.3M | Buy |
39,607
+6,747
| +21% | +$561K | ﹤0.01% | 2466 |
|
|
2021
Q1 | $2.52M | Buy |
32,860
+3,230
| +11% | +$248K | ﹤0.01% | 2509 |
|
|
2020
Q4 | $2.62M | Sell |
29,630
-22,223
| -43% | -$1.96M | ﹤0.01% | 2373 |
|
|
2020
Q3 | $3.83M | Sell |
51,853
-2,693
| -5% | -$199K | ﹤0.01% | 2059 |
|
|
2020
Q2 | $3.98M | Buy |
54,546
+35,350
| +184% | +$2.58M | ﹤0.01% | 2025 |
|
|
2020
Q1 | $1.08M | Buy |
19,196
+11,378
| +146% | +$639K | ﹤0.01% | 2487 |
|
|
2019
Q4 | $298K | Buy |
+7,818
| New | +$298K | ﹤0.01% | 3014 |
|